Understand the key differences between rheumatoid arthritis and psoriasis clinical trials and research opportunities
An autoimmune joint condition affecting ~400,000 UK adults. Biologic DMARDs and JAK inhibitors drive trial activity across treatment lines.
Affects ~1.5 million in the UK. Biologic therapies (anti-IL17, anti-IL23, anti-TNF) have transformed moderate-to-severe disease management.
RA trials focus on joint damage prevention and remission. Psoriasis trials often measure skin clearance (PASI scores) and quality of life.
Search our database of 29,000+ UK clinical trials matched to your condition and profile
Browse Disease PathwaysData sourced from ClinicalTrials.gov. Trial counts are approximate and updated regularly.
TrialConnect is a trading name of Clinical Vendor Compare Limited.